Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
PUT
IonQ
IONQ
$15.6B
| $4.18M | ﹤0.01% |
+478,200
| New | +$3.64M |
|
2227
First Merchants
FRME
$2.73B
| $4.18M | ﹤0.01% |
112,290
+53,033
| +89% | +$1.96M |
|
2228
Customers Bancorp
CUBI
$2.83B
| $4.17M | ﹤0.01% |
89,879
+28,683
| +47% | +$1.49M |
|
2229
Surgery Partners
SGRY
$2.05B
| $4.16M | ﹤0.01% |
129,133
-211,901
| -62% | -$6.26M |
|
2230
Cullinan Oncology
CGEM
$1.08B
| $4.16M | ﹤0.01% |
248,614
+51,300
| +26% | +$910K |
|
2231
Standex International
SXI
$3.91B
| $4.16M | ﹤0.01% |
22,752
+10,159
| +81% | +$1.77M |
|
2232
British American Tobacco
BTI
$128B
| $4.14M | ﹤0.01% |
113,091
-1,509,637
| -93% | -$54M |
|
2233
Kinross Gold
KGC
$28B
| $4.13M | ﹤0.01% |
441,413
-357,224
| -45% | -$3.21M |
|
|
VGR
2234
DELISTED
Vector Group Ltd.
VGR
| $4.13M | ﹤0.01% |
276,687
+222,159
| +407% | +$2.99M |
|
2235
Fluence Energy
FLNC
$2.08B
| $4.13M | ﹤0.01% |
181,766
+135,957
| +297% | +$2.46M |
|
2236
PUT
Constellation Brands
STZ
$22.4B
| $4.12M | ﹤0.01% |
+16,000
| New | +$3.97M |
|
2237
Vir Biotechnology
VIR
$1.55B
| $4.12M | ﹤0.01% |
550,186
+7,287
| +1% | +$63.3K |
|
2238
PUT
Kraft Heinz
KHC
$31.6B
| $4.11M | ﹤0.01% |
+117,000
| New | +$4.03M |
|
2239
UFP Technologies
UFPT
$2.59B
| $4.1M | ﹤0.01% |
12,937
+10,300
| +391% | +$3.28M |
|
2240
Triumph Financial Inc
TFIN
$1.91B
| $4.08M | ﹤0.01% |
51,325
+24,144
| +89% | +$2.02M |
|
2241
Privia Health
PRVA
$3B
| $4.08M | ﹤0.01% |
224,018
+158,188
| +240% | +$3.02M |
|
2242
KBR
KBR
$4.77B
| $4.08M | ﹤0.01% |
62,626
-9,145
| -13% | -$595K |
|
2243
PUT
Unity
U
$15.4B
| $4.07M | ﹤0.01% |
+180,000
| New | +$3.11M |
|
2244
CALL
LPL Financial
LPLA
$27.9B
| $4.07M | ﹤0.01% |
+17,500
| New | +$3.94M |
|
2245
NBT Bancorp
NBTB
$2.8B
| $4.06M | ﹤0.01% |
91,880
+27,085
| +42% | +$1.22M |
|
2246
Alamo Group
ALG
$2.07B
| $4.04M | ﹤0.01% |
22,417
+15,061
| +205% | +$2.68M |
|
2247
CALL
State Street
STT
$50.9B
| $4.03M | ﹤0.01% |
45,500
+14,300
| +46% | +$1.18M |
|
|
2248
PUT
State Street
STT
$50.9B
| $4.03M | ﹤0.01% |
+45,500
| New | +$3.75M |
|
2249
Hanover Insurance
THG
$7.94B
| $4.02M | ﹤0.01% |
27,155
+10,341
| +62% | +$1.42M |
|
2250
Ollie's Bargain Outlet
OLLI
$4.66B
| $4.02M | ﹤0.01% |
41,307
+15,357
| +59% | +$1.48M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.